Celltrion launches Omlyclo in Brazil, eyes Latin America growth
Story summaryCelltrion said Tuesday it has officially launched its autoimmune disease treatment Omlyclo in Brazil, the largest pharmaceutical market in Latin America, as part of its push to expand in the region.
Read at The Korea HeraldOpens the original publisher in a new tab. Full articles belong to their publishers; a subscription may be required.